<?xml version="1.0" encoding="UTF-8"?>
<ref id="B165-pathogens-09-00432">
 <label>165.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Mücke</surname>
    <given-names>V.T.</given-names>
   </name>
   <name>
    <surname>Mücke</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Peiffer</surname>
    <given-names>K.-H.</given-names>
   </name>
   <name>
    <surname>Weiler</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Welzel</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Sarrazin</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zeuzem</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Berger</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Vermehren</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>No evidence of hepatitis B virus reactivation in patients with resolved infection treated with direct-acting antivirals for hepatitis C in a large real-world cohort</article-title>
  <source>Aliment. Pharmacol. Ther.</source>
  <year>2017</year>
  <volume>46</volume>
  <fpage>432</fpage>
  <lpage>439</lpage>
  <pub-id pub-id-type="doi">10.1111/apt.14177</pub-id>
  <?supplied-pmid 28627791?>
  <pub-id pub-id-type="pmid">28627791</pub-id>
 </element-citation>
</ref>
